FAK-IN-4
FAK-IN-4 (Compound 7d) is potential FAK inhibitor with anticancer activities. FAK-IN-4 induces cell apoptosis[1].
Product Specifications
CAS Number
3032200-62-4
UNSPSC
12352005
Target
Apoptosis; FAK
Type
Reference compound
Related Pathways
Apoptosis; Protein Tyrosine Kinase/RTK
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/fak-in-4.html
Solubility
10 mM in DMSO
Smiles
CN(CCN(C1=NC=CC=C1)C(/C=C/C2=CNC3=C2C=CC=C3)=O)C
Molecular Formula
C20H22N4O
Molecular Weight
334.41
References & Citations
[1]Fei Yang, et al. Discovery of novel chloropyramine-cinnamic acid hybrids as potential FAK inhibitors for intervention of metastatic triple-negative breast cancer. Bioorg Med Chem. 2022 Jul 15;66:116809.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNUB2060-500 1x 500 µL
PAX5 / BSAP (Early B-Cell Marker) (PAX5/2060), 0.2mg/mL
Sign In for Pricing
View Details 
BNC943143-500 1x 500 µL
Ubiquitin (Autophagy Marker) (UBB/3143R), CF594 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC041692-500 1x 500 µL
Cytokeratin 16 (KRT16) (Suprabasal Keratinocyte Marker) (LL025), CF405S conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
TP320075 20 µg
67kDa Laminin Receptor (RPSA) (NM_001012321) Human Recombinant Protein
Sign In for Pricing
View Details 
LC401068 20 µg
Solute carrier family 22 member 5 (SLC22A5) (NM_003060) Human Over-expression Lysate
Sign In for Pricing
View Details